Current evidence supporting simultaneous prophylactic gastropexy in canine patients undergoing complete splenectomy
a Knowledge Summary by
Olivia Harris BS 1*
Wanda J Gordon-Evans DVM PhD DACVS DACVSMR 1
1University of Minnesota College of Veterinary Medicine, 1365 Gortner Ave, St Paul, MN 55108, USA
*Corresponding Author (olivia.harris@westvet.net)
Vol 6, Issue 4 (2021)
Published: 24 Dec 2021
Reviewed by: Zofia Lisowski (PhD FHEA BVSc) and April L Paul (DVM DACVECC)
Next review date: 15 Jun 2021
DOI: 10.18849/VE.V6I4.443
In dogs that have undergone a complete splenectomy, does performing a concurrent gastropexy decrease the risk of future gastric dilatation-volvulus (GDV) development when compared to not performing a concurrent gastropexy?
Clinical bottom line
Category of research question
Risk
The number and type of study designs reviewed
Five papers were critically reviewed which included one retrospective case series, one retrospective case-control study, and three combined retrospective cohort and cross-sectional survey studies
Strength of evidence
Weak
Outcomes reported
In dogs that have had a complete splenectomy, there is no conclusive evidence that prophylactic gastropexy decreases the risk of lifetime GDV development
Conclusion
Based on the limited information available, it is difficult to conclude if prophylactic gastropexy should be recommended routinely at the time of complete splenectomy
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
The evidence
The evidence available consists of all retrospective studies. Retrospective studies are low on the hierarchy of evidence due to the difficulty in avoiding sources of bias and confounding. Inconsistent findings were found between the critically reviewed studies and could be due to a variety of reasons including study design, disease processes that led to complete splenectomy, inclusion and exclusion criteria, and inconsistent follow-up times, among other reasons. Based on the weak level of evidence and inconsistent findings, it is difficult to make a conclusion regarding the benefit of performing concurrent gastropexy in dogs receiving splenectomy.
Summary of the evidence
Population: | Dogs that underwent exploratory laparotomy with suspected primary splenic torsion (PST) between August 1992 and May 2014 at seven referral hospitals. |
Sample size: | 102 dogs with PST. |
Intervention details: |
|
Study design: | Retrospective multi-centre case series. |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
|
Limitations: |
|
Population: | Retrospective Study #1:
Retrospective Study #2:
|
Sample size: | Retrospective Study #1:
Retrospective Study #2:
|
Intervention details: | Retrospective Study #1:
Retrospective Study #2:
|
Study design: | Retrospective single-centre cohort study and cross-sectional survey. |
Outcome Studied: | Retrospective Study #1:
Retrospective Study #2:
|
Main Findings (relevant to PICO question): |
Retrospective Study #1:
Retrospective Study #2:
|
Limitations: |
|
Population: | Dogs that underwent splenectomy between January 2002 and February 2010 at Angell Animal Medical Center. |
Sample size: | 172 Dogs that underwent splenectomy were compared to 47 sex-matched dogs that underwent enterotomy. |
Intervention details: |
|
Study design: | Retrospective single-centre cohort study and cross-sectional survey. |
Outcome Studied: | Whether dogs undergoing splenectomy had an increased risk of GDV, especially in breeds considered to be at high risk for GDV, compared with a control group of dogs undergoing enterotomy. |
Main Findings (relevant to PICO question): |
|
Limitations: |
|
Population: | Medium- to large-breed dogs that had undergone surgery with a vessel sealing or a stapling device at Ocean State Veterinary Specialists from 2008 to 2015. |
Sample size: | 238 dogs that underwent splenectomy and 209 dogs that underwent emergency laparotomy. Dogs that had a gastropexy at any point prior to or during the study were excluded. |
Intervention details: |
|
Study design: | Retrospective single-centre cohort study and cross-sectional survey. |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
|
Limitations: |
|
Population: | Dogs that underwent exploratory laparotomy or abdominal ultrasonography at either the Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania from August 2004 to August 2009 or the Veterinary Medical and Surgical Group in Ventura, California from January 2006 to August 2009. |
Sample size: | 151 dogs treated surgically for GDV and 302 control dogs with no history of GDV. Controls were matched within 3 years of age and 5 kg to case dogs and related as closely as possible in regard to sex, neuter status, and breed. |
Intervention details: | Medical records were searched for dogs that underwent exploratory laparotomy or abdominal ultrasonography. |
Study design: | Retrospective multi-centre case-control study. |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
|
Limitations: |
|
Appraisal, application and reflection
Gastric dilatation-volvulus (GDV) is a life-threatening condition in which the stomach dilates and rotates on its mesenteric axis. While this disease process is more commonly recognised in large- to giant-breed dogs, a study performed by Maki et al. (2017) revealed that GDV development is a documented post-surgical complication in some patients that have undergone a splenectomy.
It has been suggested in the veterinary literature that a prophylactic gastropexy should be considered in dogs that have undergone complete splenectomy to decrease the lifetime risk of GDV development, but the basis for this recommendation has been anecdotal. While there may be a perceived benefit to performing a gastropexy in any large- or giant-breed dogs undergoing a splenectomy, the current literature does not provide a true consensus. It may be that breeds predisposed to splenic torsion are also predisposed to development of GDV instead of a causative relationship between complete splenectomy and GDV development. Grange et al. (2012) discussed that a gastropexy is a relatively routine procedure that may help prevent GDV development, which is a life-threatening and quickly progressive disease, but could not find causation to perform a gastropexy in patients undergoing a previous complete splenectomy. Goldhammer et al. (2010) evaluated 33 dogs presenting for a non-elective gastropexy procedure due to GDV and noted that no study patients had a history of a previous splenectomy being performed. DeGroot et al. (2016) also found no statistical significance between GDV development in post-splenectomy patients (1/49 dogs) compared to patients that had not undergone a previous splenectomy (1/15 dogs). Hypotheses as to why there anecdotally may be an increased risk of GDV development secondary to complete splenectomy include increased laxity of gastric ligaments secondary to transection and increased intra-abdominal dead space, both of which allow for increased gastric mobility in the abdominal cavity.
DeGroot et al. (2016), a retrospective case series, could not draw meaningful conclusions regarding the importance of prophylactic gastropexy after complete splenectomy secondary to PST as there was no significant difference in the percentage of dogs with and without gastropexy that developed GDV. Goldhammer et al. (2010), Grange et al. (2012), and Maki et al. (2017), all of which were retrospective cohort studies with a cross-sectional survey component, drew similar conclusions to DeGroot et al. (2016) in that it was difficult to draw clinical conclusions based on results of their respective studies and further research was needed. Sartor et al. (2013), a retrospective case-control study, found results that conflicted with the previously mentioned studies. To the author’s knowledge, this is the only study truly documenting an increased odds of previous splenectomy having been performed in GDV patients, but it is difficult to draw meaningful clinical conclusions regarding the PICO question from these results as cases were compared to a general population of dogs that were presented to the veterinary hospital for a wide variety of ailments. In Sartor et al. (2013), they found that the odds of GDV in dogs with a history of previous splenectomy were significantly increased compared to those of dogs without a history of previous splenectomy, but the authors did not discuss whether any cases or controls had a gastropexy procedure previously and also did not discuss the aetiology of why a complete splenectomy was performed in the patients.
Grange et al. (2012) made an important point that while performing a prophylactic gastropexy is a relatively routine procedure, it is crucial to remember that the procedure is not without risk. Possible complications of prophylactic gastropexy, while rare, include anaesthetic complications, surgical failure with need for possible repair, changes in gastric motility, leakage of caustic stomach contents into the abdominal cavity secondary to full-thickness tissue penetration, and other complications related to increased surgery and anaesthesia time. It is essential to take into consideration individual patient factors when deciding if the benefit of an extra surgical procedure outweighs the risks. The documented complication rates for a gastropexy depends on the specific technique utilised with a recent shift towards a more minimally invasive procedure. Loy Son et al. (2016) evaluated complications following laparoscopic-assisted gastropexy in dogs. This study noted an intraoperative complication rate of 4-10% which included organ laceration, unsatisfactory suture location, and surgical access issues. A postoperative complication rate of 34% was found secondary to surgical site abnormalities (swelling, bruising, erythema, seroma formation, surgical site infection) with a majority of complications being minor and self-limiting.
Further research is needed in order to answer this PICO question. More ideal study designs include prospective cohort or case-control studies with follow-up information taken over the course of each dog’s lifetime, but ethical dilemmas may preclude these studies from progressing. Currently, there is no strong evidence that shows causation between complete splenectomy and GDV development, so it is difficult to draw clinical conclusions as to if a concurrent prophylactic gastropexy during and / or soon after complete splenectomy is of benefit to the general population of canine patients.
Methodology Section
Search Strategy | |
Databases searched and dates covered: | PubMed on NCBI Platform; 1984–2020
CAB Abstracts on OVID Platform; 1973–2020 |
Search strategy: | PubMed and CAB Abstracts:
(dog OR canine) AND (GDV OR gastric dilatation OR gastric dilatation volvulus OR gastropexy OR bloat) AND (splenectomy OR spleen) |
Dates searches performed: | 15 Jun 2021 |
Exclusion / Inclusion Criteria | |
Exclusion: |
|
Inclusion: |
|
Search Outcome | ||||||
Database |
Number of results |
Excluded – Review |
Excluded – Not relevant |
Excluded – Full article not available |
Excluded – One animal study |
Total relevant papers |
PubMed |
23 | 2 | 15 | 0 | 1 | 5 |
CAB Abstracts |
36 | 2 | 29 | 0 | 3 | 2 |
Total relevant papers when duplicates removed |
5 |
The authors declare no conflicts of interest.
Intellectual Property Rights
Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant to RCVS Knowledge a non-exclusive licence to publish including but not limited to the right to publish, re-publish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to licence or permit others to do so.
Disclaimer
Knowledge Summaries are a peer-reviewed article type which aims to answer a clinical question based on the best available current evidence. It does not override the responsibility of the practitioner. Informed decisions should be made by considering such factors as individual clinical expertise and judgement along with patient’s circumstances and owners’ values. Knowledge Summaries are a resource to help inform and any opinions expressed within the Knowledge Summaries are the author's own and do not necessarily reflect the view of the RCVS Knowledge. Authors are responsible for the accuracy of the content. While the Editor and Publisher believe that all content herein are in accord with current recommendations and practice at the time of publication, they accept no legal responsibility for any errors or omissions, and make no warranty, express or implied, with respect to material contained within. For further information please refer to our Terms of Use.